OWD
ACUR

Osborn Williams & Donohoe’s Acura Pharmaceuticals ACUR Stock Holding History

Osborn Williams & Donohoe’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15,767
Closed -$148K – 228
2013
Q2 		$148K Buy
+15,767
New +$178K 0.04% 205

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Osborn Williams & Donohoe's ACUR Position: Q3 2013 in Review

Osborn Williams & Donohoe sold out of Acura Pharmaceuticals (ACUR) in Q3 2013, closing a stake of 15,767 shares — an estimated $148K sold.

Osborn Williams & Donohoe first reported a position in ACUR in Q2 2013 and held it in 1 quarter. The position peaked at $148K in Q2 2013. 30 funds tracked by Wall St. Rank hold ACUR as of Q3 2013.

  • Osborn Williams & Donohoe reported no remaining Acura Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 15,767 Acura Pharmaceuticals shares in Q3 2013, an estimated $148K.
  • Osborn Williams & Donohoe first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Acura Pharmaceuticals position peaked at $148K in Q2 2013.
  • 30 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2013.

Based on Osborn Williams & Donohoe's 13F filing for Q3 2013, filed 9 Oct 2013.